Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

Biosimilars present a necessary and timely opportunity for physicians, patients and healthcare systems. If suitably developed clinically, manufactured to the correct standards and used appropriately, they can positively impact on the financial sustainability of healthcare systems. A critical conside...

詳細記述

保存先:
書誌詳細
出版年:ESMO Open
主要な著者: Tabernero, Josep, Vyas, Malvika, Giuliani, Rosa, Arnold, Dirk, Cardoso, Fatima, Casali, Paolo G, Cervantes, Andres, Eggermont, Alexander MM, Eniu, Alexandru, Jassem, Jacek, Pentheroudakis, George, Peters, Solange, Rauh, Stefan, Zielinski, Christoph C, Stahel, Rolf A, Voest, Emile, Douillard, Jean-Yves, McGregor, Keith, Ciardiello, Fortunato
フォーマット: Artigo
言語:Inglês
出版事項: ESMO Open 2017
主題:
Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5419210/
https://ncbi.nlm.nih.gov/pubmed/28848668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000142
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料